These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency. Shen X; Storm T; Kay MA Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459 [TBL] [Abstract][Full Text] [Related]
23. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]
24. A CRISPR Screen Identifies the Cell Polarity Determinant Crumbs 3 as an Adeno-associated Virus Restriction Factor in Hepatocytes. Madigan VJ; Tyson TO; Yuziuk JA; Pillai M; Moller-Tank S; Asokan A J Virol; 2019 Nov; 93(21):. PubMed ID: 31391273 [TBL] [Abstract][Full Text] [Related]
25. Structural Study of Aavrh.10 Receptor and Antibody Interactions. Mietzsch M; Yu JC; Hsi J; Chipman P; Broecker F; Fuming Z; Linhardt RJ; Seeberger PH; Heilbronn R; McKenna R; Agbandje-McKenna M J Virol; 2021 Nov; 95(23):e0124921. PubMed ID: 34549984 [TBL] [Abstract][Full Text] [Related]
26. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Girod A; Ried M; Wobus C; Lahm H; Leike K; Kleinschmidt J; Deléage G; Hallek M Nat Med; 1999 Sep; 5(9):1052-6. PubMed ID: 10470084 [TBL] [Abstract][Full Text] [Related]
27. Structural insight into the unique properties of adeno-associated virus serotype 9. DiMattia MA; Nam HJ; Van Vliet K; Mitchell M; Bennett A; Gurda BL; McKenna R; Olson NH; Sinkovits RS; Potter M; Byrne BJ; Aslanidi G; Zolotukhin S; Muzyczka N; Baker TS; Agbandje-McKenna M J Virol; 2012 Jun; 86(12):6947-58. PubMed ID: 22496238 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. Johnson JS; Samulski RJ J Virol; 2009 Mar; 83(6):2632-44. PubMed ID: 19109385 [TBL] [Abstract][Full Text] [Related]
29. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism. Shi W; Bartlett JS Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115 [TBL] [Abstract][Full Text] [Related]
30. Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4. Shen S; Troupes AN; Pulicherla N; Asokan A J Virol; 2013 Dec; 87(24):13206-13. PubMed ID: 24067974 [TBL] [Abstract][Full Text] [Related]
31. Receptor Switching in Newly Evolved Adeno-associated Viruses. Havlik LP; Das A; Mietzsch M; Oh DK; Ark J; McKenna R; Agbandje-McKenna M; Asokan A J Virol; 2021 Sep; 95(19):e0058721. PubMed ID: 34232726 [TBL] [Abstract][Full Text] [Related]
33. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. Opie SR; Warrington KH; Agbandje-McKenna M; Zolotukhin S; Muzyczka N J Virol; 2003 Jun; 77(12):6995-7006. PubMed ID: 12768018 [TBL] [Abstract][Full Text] [Related]
34. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692 [TBL] [Abstract][Full Text] [Related]
35. Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging. Bleker S; Pawlita M; Kleinschmidt JA J Virol; 2006 Jan; 80(2):810-20. PubMed ID: 16378983 [TBL] [Abstract][Full Text] [Related]
36. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302 [TBL] [Abstract][Full Text] [Related]